Volume 14 • Issue 5 • May 2020 ISSN 1814 3601...Singapore 157 27.9 81 14.2 37 6.4 162 27.6 5.9...
10
Volume 14 • Issue 5 • May 2020 ISSN 1814 3601 Figure 1. Incidence rate of measles cases with rash onset 1–31 March 2020, WHO Western Pacific Region Pacific island countries and areas DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved *Map of Australia is from the Australian Bureau of Statistics Table 1. Numbers of confirmed and total (confirmed and compatible) measles cases by month of rash onset, November 2019–April 2020, WHO Western Pacific Region Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 May 2020 No. of confirmed Total no. of cases No. of confirmed Total no. of cases No. of confirmed Total no. of cases No. of confirmed Total no. of cases No. of confirmed Total no. of cases No. of confirmed Total no. of cases Australia 1 29 29 18 18 21 21 4 4 0 0 0 0 Brunei Darussalam 0 0 0 0 0 0 0 0 0 0 0 0 Cambodia 92 92 70 70 83 83 163 163 63 63 30 30 China 176 185 221 223 148 151 46 54 44 47 42 52 China, Hong Kong SAR 3 3 1 1 0 0 0 0 1 1 0 0 China, Macao SAR 0 0 0 0 0 0 0 0 0 0 0 0 Japan 9 9 7 8 3 3 4 4 3 3 - - Lao People's Democratic Republic 75 75 188 188 70 73 24 24 6 6 0 0 Malaysia 93 96 73 77 45 46 66 70 54 59 16 16 Mongolia 0 0 0 0 0 0 0 0 0 0 0 0 New Zealand 152 152 51 52 7 7 0 0 0 0 0 0 Papua New Guinea 0 0 3 3 1 1 1 1 0 0 0 1 Philippines 155 671 66 425 459 1458 319 1208 49 571 2 91 Republic of Korea 2 2 2 2 3 3 3 3 0 0 0 0 Singapore 1 1 1 1 5 5 2 2 3 3 0 1 Viet Nam 43 83 4 18 84 119 61 100 20 31 0 3 Pacific island countries and areas 3958 3958 2366 2366 46 46 9 9 1 1 0 0 Western Pacific Region 4788 5356 3071 3452 975 2016 702 1642 244 785 90 194 "-" No data 1 Reports only confirmed cases 2020 2019 Mar Country/area Apr Nov Dec Jan Feb Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 May 2020
Transcript of Volume 14 • Issue 5 • May 2020 ISSN 1814 3601...Singapore 157 27.9 81 14.2 37 6.4 162 27.6 5.9...
Volume 14 • Issue 5 • May 2020 ISSN 1814 3601
Figure 1. Incidence rate of measles cases with rash onset 1–31 March 2020, WHO Western Pacific Region
Pacific island countries and areas
DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved *Map of Australia is from the Australian Bureau of Statistics
Table 1. Numbers of confirmed and total (confirmed and compatible) measles cases by month of rash onset, November 2019–April 2020, WHO Western Pacific Region
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 May 2020
No. of confirmed
Total no. of cases
No. of confirmed
Total no. of cases
No. of confirmed
Total no. of cases
No. of confirmed
Total no. of cases
No. of confirmed
Total no. of cases
No. of confirmed
Total no. of cases
Australia1 29 29 18 18 21 21 4 4 0 0 0 0Brunei Darussalam 0 0 0 0 0 0 0 0 0 0 0 0Cambodia 92 92 70 70 83 83 163 163 63 63 30 30China 176 185 221 223 148 151 46 54 44 47 42 52China, Hong Kong SAR 3 3 1 1 0 0 0 0 1 1 0 0China, Macao SAR 0 0 0 0 0 0 0 0 0 0 0 0Japan 9 9 7 8 3 3 4 4 3 3 - -Lao People's Democratic Republic 75 75 188 188 70 73 24 24 6 6 0 0Malaysia 93 96 73 77 45 46 66 70 54 59 16 16Mongolia 0 0 0 0 0 0 0 0 0 0 0 0New Zealand 152 152 51 52 7 7 0 0 0 0 0 0Papua New Guinea 0 0 3 3 1 1 1 1 0 0 0 1Philippines 155 671 66 425 459 1458 319 1208 49 571 2 91Republic of Korea 2 2 2 2 3 3 3 3 0 0 0 0Singapore 1 1 1 1 5 5 2 2 3 3 0 1Viet Nam 43 83 4 18 84 119 61 100 20 31 0 3Pacific island countries and areas 3958 3958 2366 2366 46 46 9 9 1 1 0 0Western Pacific Region 4788 5356 3071 3452 975 2016 702 1642 244 785 90 194"-" No data1 Reports only confirmed cases
20202019Mar
Country/areaAprNov Dec Jan Feb
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 May 2020
Figure 2. Total (confirmed and compatible) measles cases by month of rash onset, WHO Western Pacific Region, 2015–2020 as of 20 May 2020
0
2 000
4 000
6 000
8 000
10 000
12 000
14 000
16 000
18 000Ja
nFe
bM
ar Apr
May Jun Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar Apr
May Jun Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar Apr
May Jun Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar Apr
May Jun Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar Apr
May Jun Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar Apr
2015 2016 2017 2018 2019 2020
Num
ber o
f mea
sles
cas
es
China Malaysia Mongolia Papua New Guinea Philippines Viet Nam Others
Source: Measles and rubella monthly country reports to WHO by 20 May 2020
Table 2. Status of verification of measles elimination, WHO Western Pacific Region
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 May 2020
Imported Import-related Endemic
Unknown/ not
reportedImported Import-
related EndemicUnknown
/ not reported
Australia 2014 285 106 149 0 30 89.5% 25 12 4 0 9 64.0%Brunei Darussalam 2015 1 1 0 0 0 100.0% 0 - - - - -Cambodia 2015 676 0 0 0 679 0.0% 339 0 0 0 339 0.0%China - 2 990 0 0 0 2 990 0.0% 280 0 0 0 237 0.0%China, Hong Kong SAR 2016 90 39 42 0 9 90.0% 1 0 0 0 1 0.0%China, Macao SAR 2014 36 18 17 0 0 97.2% 0 - - - - -Japan 2015 737 116 500 0 121 83.6% 10 3 1 0 6 40.0%Lao People's Democratic Republic - 1 037 0 0 0 785 0.0% 100 0 0 0 100 0.0%Malaysia - 1 050 5 0 854 191 81.8% 181 1 0 158 22 87.8%Mongolia - 2 0 0 0 2 0.0% 0 - - - - -New Zealand 2017 2 173 28 469 0 1 680 22.9% 7 1 3 0 3 57.1%Papua New Guinea - 3 0 0 0 3 0.0% 2 0 0 0 2 0.0%Philippines - 6 792 255 14 4 995 1 528 77.5% 829 52 0 598 179 78.4%Republic of Korea 2014 190 86 101 0 3 98.4% 6 6 0 0 0 100.0%Singapore 2018 152 33 2 0 117 23.0% 10 2 0 0 8 20.0%Viet Nam - 3 300 0 0 0 3 300 0.0% 165 0 0 0 165 0.0%Pacific island countries and areas - 6 346 0 0 0 6 346 0.0% 56 0 0 0 56 0.0%Total 25 860 687 1 294 5 849 17 784 30.3% 2 011 77 8 756 1 127 41.8%
Blue No measles casesGreen ≥80%Yellow 60–79%Red <60%
2020
No. of confirmed
cases
Source of infection % of cases with known
source of infection
2019
No. of confirmed
cases
Country/area Year verified
Source of infection % of cases with known
source of infection
2
3
Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2016—2020 as of 20 May 2020
Clinically compatible Lab Epi-
linked
Total confirmed
and clinically
compatible1
Annualized measles
incidence per 1 million pop.
Australia 99 4.1 81 3.3 101 4.1 285 11.4 25.4 NA3 0 0 0 25 0 25 3.0 0 26-Feb-20
Brunei Darussalam 1 2.4 0 0.0 1 2.3 1 2.3 0.4 6 0 6 0 0 0 0 0.0 0 13-Sep-19
Cambodia 56 3.6 10 0.6 3 0.2 676 41.0 16.7 1 149 40 770 0 339 0 339 60.8 1 21-Apr-20
China 24 839 17.7 5 993 4.3 3 975 2.8 3 098 2.2 1424.5 4 927 287 4 336 24 279 1 304 0.6 0 29-Feb-20
China, Hong Kong SAR 9 1.2 4 0.5 16 2.2 90 12.0 7.5 3 0 2 0 1 0 1 0.4 0 24-Mar-20
China, Macao SAR 0 0.0 2 3.2 3 4.7 36 56.1 0.7 5 0 5 0 0 0 0 0.0 0 6-May-19
Japan 163 1.3 188 1.5 279 2.2 761 6.0 126.5 291 24 122 0 10 0 10 0.2 0 17-Mar-20
Lao People's Democratic Republic 8 1.2 3 0.4 10 1.4 1 119 158.4 7.2 226 26 97 3 32 68 103 43.1 0 19-Mar-20
Malaysia 1 587 50.9 1 693 53.5 1 958 61.1 1 077 33.2 32.9 3 003 495 2 317 10 181 0 191 17.4 0 27-Apr-20
Mongolia 28 813 9517.4 9 2.9 1 0.3 2 0.6 3.2 39 0 39 0 0 0 0 0.0 0 4-Mar-19
New Zealand 104 22.3 15 3.2 33 6.9 2 229 465.1 4.8 180 0 171 0 6 1 7 4.3 0 29-Jan-20
Papua New Guinea 0 0.0 7 0.8 15 1.8 3 0.3 8.8 104 2 98 1 2 0 3 1.0 0 6-Feb-20
Philippines 641 6.2 2 432 23.2 22 862 214.6 48 521 448.8 109.7 4 150 0 816 2 505 691 138 3 334 91.2 5 8-Apr-20
Republic of Korea 18 0.4 7 0.1 19 0.4 191 3.7 51.5 149 1 142 0 6 0 6 0.3 0 10-Feb-20
Singapore 157 27.9 81 14.2 37 6.4 162 27.6 5.9 21 0 10 1 10 0 11 5.6 0 22-Mar-20
Viet Nam 368 3.9 592 6.2 1 249 12.9 5 004 51.4 98.4 1 117 756 68 71 163 2 236 7.2 0 23-Mar-20
Pacific island countries and areas4 6 1.8 2 0.6 0 0.0 6 346 1889.5 3.4 165 8 101 0 5 0 56 49.5 0 13-Jan-20
Fiji 5 5.6 1 1.1 0 0.0 31 33.7 0.9 114 8 101 0 5 0 5 16.2 0 5-Mar-20
New Caledonia - - 1 3.6 0 0.0 0 0.0 0.3 0 - - - - - - - - 10-Jan-17
Samoa - - - - - - 5 707 28691.5 0.2 0 - - - - - - - - 13-Jan-20
Solomon Islands 1 1.7 0 0.0 0 0.0 - - 0.6 0 - - - - - - - - 21-Jan-16
Tonga - - - - - - 608 5525.2 0.1 51 0 0 - - - 51 1377.9 0 13-Feb-20
Vanuatu 0 0.0 - - - - - - 0.3 0 - - - - - - - - 23-Sep-15
Western Pacific Region 56 869 30.1 11 119 5.8 30 562 16.0 63 286 33.0 1927.5 15 535 1 639 9 100 2 615 1 750 210 4 575 2.4 61 Includes clinically compatible, laboratory confirmed and epi-linked confirmed cases Green <1 confirmed measles case / 1 000 000 population2 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2017 revision. Yellow 1–9.9 confirmed measles case / 1 000 000 population3 Australia reports confirmed cases only. Red >= 10 confirmed cases / 1 000 000 population4 Classification is provisional based on laboratory data only.
2020
Rash onset of last
confirmed measles
case
Population (in
millions) 2
Suspected measles
cases
Pending classification
Discarded cases3
Measles cases
Deaths due to
measles
Country/area
2017
Total confirmed and
clinically compatible1
Measles incidence
per 1 million
pop.
2016
Total confirmed and
clinically compatible1
Measles incidence
per 1 million
pop.
2018 2019
Total confirmed
and clinically compatible1
Measles incidence
per 1 million
pop.
Total confirmed and
clinically compatible1
Measles incidence
per 1 million
pop.
3
4
Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2019—2020 as of 20 May 2020
Discarded non-measles rate per
100 000 pop
Annualized discarded non-measles rate per 100
000 pop
≥ 2 ≥ 2
Australia 3 Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data
Brunei Darussalam 4.6 Not applicable 100.0% 95.2% 4.0 Not applicable 83.3% 83.3%
Cambodia 9.2 96.0% 91.3% 96.4% 13.8 84.0% 91.9% 97.4%
China 5.3 77.4% 96.8% 79.7% 0.9 0.0% 95.7% 78.8%
China, Hong Kong SAR 0.1 Not applicable 100.0% 90.8% 0.1 Not applicable 100.0% 100.0%
China, Macao SAR 14.5 Not applicable 97.7% 97.7% 2.3 Not applicable 80.0% 100.0%
Japan 2.1 23.4% Insufficient data Insufficient data 0.3 0.0% Insufficient data Insufficient data
Lao People's Democratic Republic 13.0 100.0% 85.2% 85.6% 4.1 44.4% 80.4% 96.8%
Malaysia 28.2 93.8% 84.8% 91.7% 21.1 93.8% 81.4% 95.1%
Mongolia 10.6 50.0% 94.4% 95.2% 3.6 31.8% 100.0% 100.0%
New Zealand 2.0 Insufficient data Insufficient data Insufficient data 10.6 Insufficient data Insufficient data Insufficient data
Papua New Guinea 1.1 15.0% 76.6% 87.2% 3.4 35.0% 81.7% 93.3%
Philippines 1.8 27.8% 29.6% 38.6% 2.2 11.1% 43.0% 48.5%
Republic of Korea 8.7 100.0% 87.2% 97.2% 0.8 0.0% 83.2% 97.3%
Singapore 1.8 Not applicable 73.1% 73.1% 0.5 Not applicable 95.2% 76.2%
Viet Nam 0.8 14.3% 26.8% 37.7% 0.2 1.6% 7.1% 63.0%
Pacific island countries and areas4 13.4 10.0% Insufficient data 87.0% 8.9 5.0% Insufficient data 52.7%
Western Pacific Region 48.8 46.8% 66.6% 63.0% 32.8 20.9% 68.4% 72.2%Green Reached or surpassed target
Yellow Nearly reached target: 1.00–1.99 for non-measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators
Red Substantially below target
2019
Second level units with≥ 2 discarded cases per
100 000 pop [annualized]1
Suspected cases with adequate investigation
Suspected cases with adequate specimens for laboratory confirmation 2
≥ 80%
Country/area
≥ 80% ≥ 80%
2020
Second level units with≥ 2 discarded cases per
100 000 pop [annualized]1
Suspected cases with adequate investigation
Suspected cases with adequate specimens for laboratory confirmation 2
≥ 80% ≥ 80% ≥ 80%
1 This indicator is not applicable for countries which have no second-level administrative units2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked cases.3 Reports only confirmed cases4 Surveillance performance indicators refer to all the Pacific island countries and areas as one epidemiological block; each country is considered as second level unit
5
Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2016–2020 as of 20 May 2020
Clinically compatible
casesLab Epi-linked
Australia - - - - - - - - 25.40 - - - - - - - - -
Brunei Darussalam 0 0.0 0 0.0 0 0.0 0 0.0 0.44 6 0 6 0 0 0 0 0.0 -
Cambodia 4 0.3 7 0.4 3 0.2 30 1.8 16.72 1 149 41 1 095 0 13 0 13 2.3 -
China 4 476 3.2 1 601 1.1 3 935 2.8 32 568 22.9 1 424.55 4 927 287 3 212 328 932 168 1 428 3.0 -
China, Hong Kong SAR 3 0.4 1 0.1 11 1.5 48 6.4 7.55 3 0 0 0 3 0 3 1.2 -
China, Macao SAR 1 1.6 0 0.0 1 1.6 78 121.5 0.65 5 0 2 0 3 0 3 13.8 -
Japan3 3 0.0 5 0.0 68 0.5 2 394 18.9 126.50 205 13 117 5 69 1 75 1.8 -
Lao People's Democratic Republic 40 5.9 12 1.7 15 2.2 11 1.6 7.16 226 26 188 0 12 0 12 5.0 -
Malaysia 68 2.2 113 3.6 175 5.5 111 3.4 32.87 3 013 495 2 498 0 20 0 20 1.8 -
Mongolia 27 8.9 13 4.2 1 0.3 2 0.6 3.21 39 0 39 0 0 0 0 0.0 -
New Zealand - - - - - - 1 0.2 4.83 0 - - - - - - - -
Papua New Guinea 2 0.2 1 0.1 1 0.1 5 0.6 8.76 103 2 101 0 0 0 0 0.0 -
Philippines 165 1.6 448 4.3 152 1.4 198 1.8 109.70 4 150 0 3 808 0 331 11 342 9.4 -
Republic of Korea 3 0.1 2 0.0 0 0.00 8 0.2 51.51 26 0 24 0 2 0 2 0.1 -
Singapore 0 0.0 3 0.5 16 2.8 7 1.2 5.94 7 0 3 3 1 0 4 2.0 -
Viet Nam 350 3.7 126 1.3 102 1.1 85 0.9 98.36 113 38 58 14 3 0 17 0.5 -
Pacific island countries and areas2 1 0.3 4 1.2 0 0.0 0 0.0 3.40 114 8 106 0 0 0 0 0.0 -
Fiji 1 1.1 4 4.4 0 0.0 0 0.0 0.92 114 8 106 0 0 0 0 0.0 -
New Caledonia 0 0.0 0 0.0 0 0.0 0 0.0 0.29 0 - - - - - - - -
Solomon Islands - - 0 0.0 - - - - 0.65 0 - - - - - - - -
Vanuatu 0 0.0 - - - - - - 0.29 0 - - - - - - - -
Western Pacific Region 5 143 2.7 2 336 1.2 4 480 2.3 35 546 18.5 1927.54 14 086 910 11 257 350 1 389 180 1 919 3.0 -1 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2017 revision Green <1 confirmed measles case / 1 000 000 population
2 Classification is provisional based on laboratory data only. Yellow 1–9.9 confirmed measles case / 1 000 000 population
3 Rubella cases are cases reported as suspected measles cases that were identified as rubella laboratory confirmed cases during the investigation. This represents a small proportion of a large number of rubella cases occurring in Japan during 2018 Red >= 10 confirmed cases / 1 000 000 population
"-" No data Gray No data
Country/areaTotal
confirmed and clinically compatible
2016
Total confirmed
and clinically compatible
Rubella incidence per 1 million pop.
Rubella incidence per 1 million pop.
Total confirmed
and clinically compatible
Rubella incidence per 1 million pop.
2020
Population (in millions) 1
2017
Annualized Rubella
incidence per 1 million pop.
Congenital rubella
syndrome
2018 2019
Investigated for rubella
Pending classification
Discarded cases
Rubella casesTotal
confirmed and clinically compatible
Total confirmed
and clinically compatible
Rubella incidence per 1 million pop.
6
Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2019
No. No. % No. %No.
receivedNo. (+)
No. of samples tested
No. of isolates
No. of samples tested
No. (+) No. No. % No. %
Australia VIDRL 225 225 195 14 12 85.7 0 0% 0 - 92.9 57 17 209 199 192 1 1 100% 0 0%
Brunei Darussalam DLS 24 22 22 22 2 9.1 1 5% 0 - 95.8 1 1 1 0 2 22 0 0% 0 0%
Cambodia NIPH 2 195 2 195 2 195 2 116 674 31.9 2 0% 79 1 83.6 0 - 0 - 675 2 191 30 1% 0 0%
China CCDC - - - - - - - - - - 95.8 - - - - - - - - - -
China, Hong Kong SAR PHLC 2 893 2 893 1 787 1 394 59 4.2 12 1% 0 - 98.8 87 36 1 425 108 110 414 43 10% 7 2%
China, Macao SAR PHL 829 829 507 506 31 6.1 9 2% 0 - 100.0 0 - 383 52 62 505 39 8% 17 3%
Japan NIID 10 633 10 481 6 164 677 206 30.4 86 13% 0 - No data 0 - 3 018 652 737 1 604 1 171 73% 66 4%
Lao People's Democratic Republic NCLE 1 013 1 013 1 013 1 008 152 15.1 18 2% 0 - 89.2 0 - 0 - 152 1 013 14 1% 25 2%
Malaysia NPHL 18 638 18 638 12 059 11 542 1 212 10.5 231 2% 0 - 92.0 5 048 22 0 - 1 120 9 790 375 4% 171 2%
Mongolia NCCD 338 338 338 338 2 0.6 0 0% 0 - 100.0 0 - 0 - 2 337 3 1% 0 0%
New Zealand CHL 3 723 3 723 3 535 239 94 39.3 6 3% 0 - 91.5 18 0 3 487 2 095 2 062 23 2 9% 1 4%
Papua New Guinea CPHL 55 55 55 55 1 1.8 1 2% 0 - 62.5 0 - 0 - 1 55 5 9% 1 2%
Philippines RITM 29 333 8 250 8 215 8 219 4 817 58.6 281 3% 31 7 48.2 0 - 2 757 1 939 6 463 3 164 245 8% 94 3%
Republic of Korea KCDC 8 091 8 091 4 969 3 276 186 5.7 91 3% 0 - 56.7 0 - 4 350 281 375 359 57 16% 29 8%
Singapore NPHL 870 870 841 86 20 23.3 3 3% 0 - 95.3 129 49 798 138 207 86 1 1% 2 2%
Viet Nam national lab (Northern) NIHE 1 216 1 216 1 187 974 740 76.0 5 1% 0 - 99.6 183 4 241 192 916 295 9 3% 0 0%
Viet Nam national lab (Southern) PI 4 324 4 324 4 320 4 309 1 864 43.3 14 0% 0 - 53.6 15 0 15 0 1 864 3 509 29 1% 16 0%
Viet Nam subnational lab (Central) PI 1 375 1 375 1 375 1 375 1 242 90.3 9 1% 0 - 53.7 5 0 15 10 1 242 860 0 0% 1 0%
Viet Nam subnational lab (Highland) IHE 1 541 1 541 1 541 1 542 1 396 90.5 11 1% 0 - 50.4 0 - 0 - 1 395 1 028 1 0% 1 0%
Fiji FCCDC 483 472 472 444 28 6.3 14 3% 0 - No data 0 - 9 4 28 201 6 3% 0 0%
Total 87 799 66 551 50 790 38 136 12 738 33. 4 794 2% 110 8 72.2 5 543 129 16 708 5 670 17 605 25 457 2 031 8% 431 2%
"-" No data
Country/area Laboratory
Measles and rubellaMeasles Rubella
Serology Virus detection
Total number of
lab confirmed
cases
Serum and blood (includes DBS)Serum Blood
% of samples
with results ≤4
days
Measles Virus isolation/ detection
(swab, urine and others)
Measles Reverse
Transcription- Polymerase Chain
Reaction
Total number
of samples received
Total number
of samples tested
Total number of cases tested
Samples tested for
measles IgMMeasles IgM (+)
Measles IgM equiv
DBS samples Samples
tested for rubella IgM
Rubella IgM (+)Rubella
IgM equiv
7
Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2020 as of 20 May 2020
No. No. % No. %No.
receivedNo. (+)
No. of samples tested
No. of isolates
No. of samples tested
No. (+) No. No. % No. %
Australia VIDRL 21 21 20 0 - - - - 0 - - 3 0 21 20 20 0 - - - -
Brunei Darussalam DLS 6 6 6 6 0 0% 0 0% 0 - 95.8 0 - 0 - 0 6 0 0% 0 0%
Cambodia NIPH 1 095 1 095 1 095 1 095 337 31% 0 0% 26 1 99.0 0 - 0 - 337 1 100 15 1% 0 0%
China CCDC - - - - - - - - 0 - 95.8 - - - - - - - - - -
China, Hong Kong SAR PHLC 152 152 117 102 2 2% 0 0% 0 - 90.0 0 - 46 0 2 58 3 5% 0 0%
China, Macao SAR PHL 42 42 30 30 4 13% 1 3% 0 - 100.0 1 0 14 0 4 30 2 7% 0 0%
Japan NIID 451 436 277 28 9 32% 5 18% 0 - - 0 - 117 4 10 70 43 61% 8 11%
Lao People's Democratic Republic NCLE 126 126 126 126 30 24% 10 8% 0 - 75.4 0 - 0 - 30 126 12 10% 5 4%
Malaysia NPHL 5 498 5 498 3 684 3 446 377 11% 87 3% 0 - 85.2 621 0 0 - 377 3 112 117 4% 63 2%
Mongolia NCCD 39 39 39 39 0 0% 0 0% 0 - 100.0 0 - 0 - 0 39 0 0% 0 0%
New Zealand CHL 79 79 76 4 1 25% 0 0% 0 - 75.0 0 - 75 7 7 3 0 - 0 -
Papua New Guinea CPHL 81 81 81 81 4 5% 0 0% 0 - 66.7 0 - 0 - 4 81 1 1% 2 2%
Philippines RITM 2 500 2 282 2 224 2 228 964 43% 54 2% 5 1 95.4 0 - 147 52 1 006 1 266 397 31% 29 2%
Republic of Korea KCDC 344 344 220 161 14 9% 3 2% 0 - 30.9 0 - 163 8 16 69 15 22% 4 6%
Singapore NPHL 159 159 147 16 2 13% 1 6% 0 - 84.2 8 1 114 6 9 16 0 0% 0 0%
Viet Nam national lab (Northern) NIHE 41 41 41 41 40 - 0 - 0 - - 0 - 0 - 40 0 - - - -
Viet Nam national lab (Southern) PI 551 551 551 551 434 79% 4 1% 0 - - 0 - 0 - 246 124 16 13% 0 0%
Viet Nam subnational lab (Central) PI 439 439 439 439 369 - 3 - 0 - - 0 - 0 - 369 0 - - - 0%
Viet Nam subnational lab (Highland) IHE 1 1 1 1 1 100% 0 0% 0 - - 0 - 0 - 1 0 - - - -
Fiji FCCDC 117 113 113 113 5 4% 7 6% 0 - - 0 - 0 - 5 11 0 0% 0 0%
Total 11 742 11 505 9 287 8 507 2 593 30% 175 2% 31 2 90.0 633 1 697 97 2 483 6 111 621 10% 111 2%
"-" No data
Samples tested for rubella IgM
Rubella IgM (+)Rubella
IgM equivDBS samples
Total number
of samples received
Total number
of samples tested
Total number of cases tested
Samples tested for
measles IgMMeasles IgM (+)
Measles IgM equiv
Virus detection
Total number of
lab confirmed
cases
Serum and blood (includes DBS)Serum Blood
% of samples
with results ≤4
days
Measles Virus isolation/ detection
(swab, urine and others)
Measles Reverse
Transcription- Polymerase Chain
Reaction
Country/area Laboratory
Measles and rubellaMeasles Rubella
Serology
8
Figure 3. Measles genotype distribution of cases with rash onset in 2019 and 2020, WHO Western Pacific Region
Table 7. Measles genotype distribution of cases with rash onset in May 2019 to April 2020, WHO Western Pacific Region
2019 2020
B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1Australia 4 11 1 23 1 8 5 2 8 3 7 1 2 3 12 4 1Brunei Darussalam 1Cambodia 3 2 3 4China 11 36 9 8 18 1 15 15 1 11 14 10 1 3 11 1 3 6 9 3China, Hong Kong SAR 2 6 1 6 2 1 1 1 2 1China, Macao SAR 2 1Japan 53 30 11 23 2 11 8 2 1 3 1 2 1 1Lao People's Democratic RepublicMalaysia 1 9 1 8MongoliaNew Zealand 11 7 4 11 20 31 16 42 14 47 1 36 11 18 6 3 2 1Papua New GuineaPhilippines 3 6 45Republic of Korea 2 7 1 6 5 6 11 2 3 2 1Singapore 2 3 4 9 40 7 7 2 2 3 1 2 2 2 1Viet Nam 19 13 19 5 1Pacific island countries and areas 3
JulJun Sep Oct Nov Dec2019
Jan2020
Feb Mar AprAugMayCountry/area
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 May 2020
The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved.
9
Figure 4. Rubella genotype distribution of cases with rash onset in 2019 and 2020, WHO Western Pacific Region
Table 8. Rubella genotype distribution of cases with rash onset in May 2019 to April 2020, WHO Western Pacific Region
2019 2020
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 May 2020
2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J
Australia
Brunei Darussalam
Cambodia 1China 223 422 195 200 40 52 16 19 10 19 24 13 2 13 7 8 16 20 1 4China, Hong Kong SAR 1 5 4 1 2 1 1 1 1 1China, Macao SAR 20Japan 17 80 7 80 2 58 25 1 12 7 1 3 4 2 5 1 3 3Lao People's Democratic Republic
Malaysia
Mongolia
New Zealand 1Papua New Guinea
Philippines
Republic of Korea 1 1 1 1 1Singapore 1 1 1Viet Nam
Pacific island countries and areas
Sep
2019
OctMay Jun Jul Aug Nov Dec Jan Mar AprFebCountry/area
2020
The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved.
Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2019—2020
Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2019—2020
Vaccine-Preventable Diseases and Immunization Regional Office for the Western Pacific
World Health Organization
P.O. Box 2932, 1000 Manila, PhilippinesTel. No. (63 2) 85288001
Fax No. (63 2) 85211036, 85260279Please send your comments and monthly data before the 10th of the month to: [email protected]
More detailed information available in theRegional and country profile of measles elimination
Jan Feb Mar Apr
Australia 100% 92% 10 Feb 17 Mar 07 Apr 10 May 100% 75%
Brunei Darussalam 100% 100% 06 Feb 02 Mar 04 Apr 07 May 100% 100%
Cambodia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
China 100% 33% 15 Feb 17 Mar 03 Apr 05 May 100% 100%
China, Hong Kong SAR 92% 92% 07 Feb 06 Mar 08 Apr 06 May 100% 100%
China, Macao SAR 100% 100% 10 Feb 09 Mar 08 Apr 07 May 100% 100%
Japan 100% 67% 11 Feb 23 Mar 29 Apr - 75% 0%
Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Malaysia 100% 83% 10 Feb 09 Mar 06 Apr 06 May 100% 100%
Mongolia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
New Zealand 100% 100% 10 Feb 10 Mar 08 Apr 08 May 100% 100%
Papua New Guinea 75% 25% 10 Feb 10 Mar 08 Apr 09 May 100% 100%
Philippines 67% 17% 19 Feb 13 Mar 28 Apr 10 May 100% 50%
Republic of Korea 92% 33% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Singapore 100% 100% 10 Feb 09 Mar 07 Apr 08 May 100% 100%
Viet Nam 92% 92% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Pacific island countries and areas 100% 92% 14 Feb 13 Mar 14 Apr 14 May 100% 100%
Completeness 95% 100% 100% 100% 94% 99%
Timeliness 78% 88% 82% 88% 94% 90%1 National measles surveillance monthly reports from April 2020. Legend: black = timely report; red = untimely report
Completeness 2 Timeliness 3Country
2019
3 Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office by the 15th (or the next working day) of the following month.
2020 1
2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.
Completeness 2 Timeliness 3
Australia 100% 92% 07 Feb 06 Mar 01 Apr 04 May 100% 100%
Brunei Darussalam 100% 100% 07 Feb 02 Mar 02 Apr 02 May 100% 100%
Cambodia 100% 108% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
China 100% 100% 06 Feb 02 Mar 01 Apr 06 May 100% 100%
China, Hong Kong SAR 100% 100% 07 Feb 06 Mar 08 Apr 06 May 100% 100%
China, Macao SAR 100% 100% 10 Feb 10 Mar 10 Apr 08 May 100% 100%
Japan 100% 58% 11 Feb 23 Mar 29 Apr - 75% 0%
Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Malaysia 100% 83% 12 Feb 11 Mar 08 Apr 08 May 100% 50%
Mongolia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
New Zealand 100% 100% 10 Feb 10 Mar 08 Apr 08 May 100% 100%
Papua New Guinea 75% 67% 06 Feb 10 Mar - - 50% 50%
Philippines 92% 83% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Republic of Korea 100% 100% 10 Feb 10 Mar 10 Apr 08 May 100% 100%
Singapore 100% 100% 09 Feb 09 Mar 07 Apr 08 May 100% 100%
Viet Nam national lab (Northern) 100% 92% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Viet Nam national lab (Southern) 100% 100% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Viet Nam subnational lab (Central) 100% 92% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Viet Nam subnational lab (Highland) 100% 92% 10 Feb 10 Mar 10 Apr 10 May 100% 100%
Fiji 100% 92% 15 Feb 13 Mar 14 Apr 14 May 100% 100%
Completeness 98% 100% 100% 95% 90% 96%
Timeliness 92% 85% 90% 90% 90% 90%1 National measles laboratory monthly reports from April 2020.
2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.
3 National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.
2020 1
Country/area
2019
Completeness 2 Timeliness 3 Jan Feb Mar Apr Completeness 2 Timeliness 3
